Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1

Conditions

Pleural Effusion, Malignant 5Neoplasm Metastasis 4Solitary Fibrous Tumor, Pleural 1Mesothelioma, Malignant 1Mesothelioma 1Lung Diseases 1

Interventions

Carboplatin 6Pemetrexed 4pembrolizumab 3Cisplatin 3Paclitaxel 2Gemcitabine 2Docetaxel 2zipalertinib 1zimberelimab 1sacituzumab govitecan 1pralsetinib 1patritumab 1camrelizumab 1alectinib 1Vinorelbine 1Thrombin 1Talc 1TachoSil 1TNFSF10 protein, human 1Surveys and Questionnaires 1Nivolumab 1Injections 1Fibrinogen 1Erlotinib Hydrochloride 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Lung Diseases × Talc × Clear all
NCT02511600 2015-12-15

Comparison of Progel Sealant to Standard of Care (SOC) for Patients Undergoing Decortication

M.D. Anderson Cancer Center

Phase 3 Withdrawn
Other solid neoplasmThoracic

Lung Diseases, Mesothelioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡